Researchers Attend MS Milan 2023

Last week, our scientist attended #MSMilan2023. The event was jointly hosted by #Ectrims & #Actrims and gathered MS experts from across the globe to meet and discuss some of the groundbreaking MS news and research.

Our team shared and present 5 different topics: 
 

• PAK1 and E2F1 dysregulation induces a p21-mediated defect of oligodendrocyte differentiation in a cerebral organoids model of multiple sclerosis

• In vitro infection of CNS-derived cells with Epstein-Barr virus using a B-cell transfer method

• Pathogenic cerebrospinal fluid antibodies in oligoclonal band-negative primary progressive MS patients

• Intrathecal Cell Therapy is Associated with a Reduction in Inflammatory Biomarkers in Cerebrospinal Fluid of Progressive MS Patients 

• Investigation of cerebrospinal fluid antibody specificity in primary progressive MS